Arcturus Therapeutics (ARCT) Tops Q3 EPS by $1.01

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to Arcturus Therapeutics (ARCT) Tops Q3 EPS by $1.01

Arcturus Therapeutics Announces Third Quarter 2023 Financial Update and Pipeline Progress

November 14, 2023 4:01 PM EST

Expected cash runway extended to the end of 2026

$35 million milestone achieved under CSL collaboration

ARCT-154 remains on track for Japan-NDA approval in December

Enrollment target reached in Phase 3 bivalent COVID vaccine comparison trial

Enrollment initiated in ARCT-032 Phase 1b study; dosing first cystic fibrosis patient this month

ARCT-032 received Rare Pediatric Disease Designation for cystic fibrosis from the FDA

Investor conference call at 4:30 p.m. ET November 14, 2023

SAN DIEGO--(BUSINESS WIRE)-- Arcturus... More